T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Arcutis Biotherapeutics
ARQT
$3.25B
| $29.2M | ﹤0.01% |
+980,614
| New | +$26.3M |
|
952
uniQure
QURE
$3.26B
| $29.1M | ﹤0.01% |
612,987
+120,061
| +24% | +$6.9M |
|
953
Murphy USA
MUSA
$10.4B
| $29.1M | ﹤0.01% |
344,534
-173,434
| -33% | -$18M |
|
954
Nexstar Media Group
NXST
$5.81B
| $29M | ﹤0.01% |
502,158
-738
| -0.1% | -$78.1K |
|
955
Marriott Vacations Worldwide
VAC
$4.17B
| $28.6M | ﹤0.01% |
515,256
-22,406
| -4% | -$2.33M |
|
956
Carnival Corporation Ltd
CCL
$38.9B
| $28.6M | ﹤0.01% |
2,169,160
-2,268,837
| -51% | -$80.7M |
|
957
M&T Bank
MTB
$36.6B
| $28.3M | ﹤0.01% |
273,449
+13,978
| +5% | +$2.06M |
|
|
PGTI
958
DELISTED
PGT, Inc.
PGTI
| $28.3M | ﹤0.01% |
3,367,781
-48,280
| -1% | -$686K |
|
959
Elastic
ESTC
$8.94B
| $28.1M | ﹤0.01% |
503,420
+157,212
| +45% | +$10.2M |
|
960
Utah Medical Products
UTMD
$230M
| $28.1M | ﹤0.01% |
298,622
-20,061
| -6% | -$1.86M |
|
961
Addus HomeCare
ADUS
$2.2B
| $28M | ﹤0.01% |
414,284
-43,889
| -10% | -$3.8M |
|
962
REX American Resources
REX
$1.44B
| $28M | ﹤0.01% |
3,607,800
+155,088
| +4% | +$1.76M |
|
963
Commault Systems
CVLT
$6.26B
| $27.9M | ﹤0.01% |
688,878
+14,753
| +2% | +$637K |
|
964
Pebblebrook Hotel Trust
PEB
$2.05B
| $27.8M | ﹤0.01% |
2,556,139
+364,758
| +17% | +$7.42M |
|
|
HCCI
965
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $27.8M | ﹤0.01% |
1,710,460
-5,417
| -0.3% | -$137K |
|
966
Stoneridge
SRI
$201M
| $27.6M | ﹤0.01% |
1,647,131
-57,018
| -3% | -$1.41M |
|
|
IPHI
967
DELISTED
INPHI CORPORATION
IPHI
| $27.5M | ﹤0.01% |
346,915
-634,960
| -65% | -$49.4M |
|
968
Goosehead Insurance
GSHD
$2.39B
| $27.5M | ﹤0.01% |
615,310
-538,056
| -47% | -$26.6M |
|
969
Atkore
ATKR
$3.17B
| $27.3M | ﹤0.01% |
1,297,503
+115,692
| +10% | +$4.15M |
|
970
Huntington Ingalls Industries
HII
$12.8B
| $27.2M | ﹤0.01% |
149,029
+6,090
| +4% | +$1.42M |
|
|
RAPT
971
DELISTED
RAPT Therapeutics
RAPT
| $27.1M | ﹤0.01% |
162,636
+14,732
| +10% | +$3.36M |
|
972
Wintrust Financial
WTFC
$11B
| $27.1M | ﹤0.01% |
824,259
-77,920
| -9% | -$4.32M |
|
973
Alliant Energy
LNT
$18.2B
| $27M | ﹤0.01% |
559,636
+40,553
| +8% | +$2.22M |
|
974
Cactus
WHD
$5.78B
| $27M | ﹤0.01% |
2,324,338
+638,606
| +38% | +$16M |
|
975
Myers Industries
MYE
$1.25B
| $26.9M | ﹤0.01% |
2,499,996
-695,204
| -22% | -$10.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.